← Open Payments lookup

TRACEY WIESE: Open Payments

NPI 1467781021 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$510 in 22 payments from 10 companies in 2025. Trend: 2023 $97 · 2024 $319 · 2025 $510

Food & beverage: $510
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.6$164
ABBVIE INC.3$76
Gilead Sciences, Inc.2$48
Neurocrine BioSciences, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$41
ViiV Healthcare Company2$32
Collegium Pharmaceutical, Inc.2$32
Otsuka America Pharmaceutical, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
E.R. Squibb & Sons, L.L.C.1$18

Products named: Qelbree, VRAYLAR, INGREZZA, TRINTELLIX, Jornay PM, REXULTI, CAPLYTA, COBENFY.

Industry payments across AK — which companies pay providers there.